Basement Membrane Proteoglycans: Modulators Par Excellence of Cancer Growth and Angiogenesis

다국어 초록 (Multilingual Abstract)

Proteoglycans located in basement membranes, the nanos-tructures underling epithelial and endothelial layers, are unique in several respects. They are usually large, elon-gated molecules with a collage of domains that share structural and functional homology with numerous extracellular matrix proteins, growth factors and surface receptors. They mainly carry heparan sulfate side chains and these contribute not only to storing and preserving the biological activity of various heparan sulfate-binding cytokines and growth factors, but also in presenting them in a more “active configuration” to their cognate receptors. Abnormal expression or deregulated function of these proteoglycans affect cancer and angiogenesis, and are critical for the evolution of the tumor microenvironment. This review will focus on the functional roles of the major heparan sulfate proteoglycans from basement membrane zones: perlecan, agrin and collagen XVIII, and on their roles in modulating cancer growth and angiogenesis.

참고문헌 (Reference)

• 1 Zhang, Z, "21 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner" 111 : 1980-1988, 2008
• 2 Grenache, D.G, "Wound healing in the 21 integrin-deficient mouse: altered keratinocyte biology and dys-regulated matrix metalloproteinase expression" 127 : 455-466, 2006
• 3 Witmer, A.N, "Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies" 22 : 190-197, 2001
• 4 Robinson, C.J, "VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase" 281 : 1731-1740, 2006
• 5 O’Riordan, E, "Urinary proteomic analysis of chronic renal allograft nephropathy" 2 : 1025-1035, 2008
• 6 Krishna, J, "Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings" 7 : 221-227, 2006
• 7 Adkins, J.N, "Toward a human blood serum proteome. Analysis by multidimensional separation coupled with mass spectrometry" 1 : 947-955, 2002
• 8 Senger, D.R, "The 11 and 21 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis" 160 : 195-204, 2002
• 9 Thadikkaran, L, "The role of proteomics in the assessment of premature rupture of fetal membranes" 360 : 27-36, 2005
• 10 Mongiat, M, "The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7" 275 : 7095-7100, 2000
• 11 Whitelock, J.M, "The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases" 271 : 10079-10086, 1996
• 12 Clamp, A.R, "The clinical potential of antiangiogenic fragments of extracellular matrix proteins" 93 : 967-972, 2005
• 13 Iozzo, R.V, "The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices" 302 : 625-639, 1994
• 14 Kadenhe-Chiweshe, A, "Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation" 6 : 1-9, 2008
• 15 Adatia, R, "Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA" 8 : 1257-1261, 1998
• 16 Aviezer, D, "Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA" 17 : 1938-1946, 1997
• 17 Sasaki, T, "Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin" 17 : 4249-4256, 1998
• 18 Utriainen, A, "Structurally altered basement membranes and hydro-cephalus in a type XVIII collagen deficient mouse line" 13 : 2089-2099, 2004
• 19 Iozzo, R.V, "Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor- via a nuclear factor 1-binding element" 272 : 5219-5228, 1997
• 20 Reif, R, "Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation" 21 : 3468-3478, 2007
• 21 Hassell, J.R, "Role of perlecan in skeletal development and diseases" 19 : 263-267, 2003
• 22 Warth, A, "Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae" 107 : 311-318, 2004
• 23 Oda, O, "Purification and characterization of perlecan fragment in urine of end-stage renal failure patients" 255 : 119-132, 1996
• 24 Zoeller, J.J, "Proteomic profiling of endorepellin angiostatic activity on human endothelial cells" 6 : 7-, 2008
• 25 Tsangaris, G.T, "Proteomic analysis of amniotic fluid in pregnancies with Down syndrome" 6 : 4410-4419, 2006
• 26 Iozzo, R.V, "Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function" 10 : 598-614, 1996
• 27 Rehn, M, "Primary structure of the a1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the 1(XVIII) chain with its homologue, the 1 (XV) collagen chain" 269 : 13929-13935, 1994
• 28 Groffen, A.J.A, "Primary structure and high expression of human agrin in basement membranes of adult lung and kidney" 254 : 123-128, 1998
• 29 Marneros, A.G, "Physiological role of collagen XVIII and endostatin" 19 : 716-728, 2005
• 30 Iozzo, R.V, "Perlecan: a gem of a proteoglycan" 14 : 203-208, 1994
• 31 Farach-Carson, M.C, "Perlecan-a multifunctional extracellular proteoglycan scaffold" 17 : 897-905, 2007
• 32 Aviezer, D, "Perlecan,basal lamina proteoglycan,promotes basic fibroblast growth factor-receptor binding,mitogenesis,and angiogenesis" 79 : 1005-1013, 1994
• 33 Laplante, P, "Perlecan proteolysis induces 21 integrin and src-family kinases dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation" 281 : 30383-30392, 2006
• 34 Costell, M, "Perlecan maintains the integrity of cartilage and some basement membranes" 147 : 1109-1122, 1999
• 35 Savoré, C, "Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo" 22 : 377-390, 2005
• 36 Nugent, M.A, "Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia" 97 : 6722-6727, 2000
• 37 Arikawa-Hirasawa, E, "Perlecan is essential for cartilage and cephalic development" 23 : 354-358, 1999
• 38 Klein, G, "Perlecan in human bone marrow: a growth-factor presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells" 14 : 457-465, 1995
• 39 Fuki, I, "Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism" 275 : 25742-25750, 2000
• 40 Kuo, C.J, "Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/ endostatin domain" 152 : 1233-1246, 2001
• 41 Bix, G, "Novel interactions of perlecan: Unraveling perlecan’s role in angiogenesis" 71 : 339-348, 2008
• 42 Laplante, P, "Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis" 174 : 5740-5749, 2005
• 43 Bezakova, G, "New insights into the roles of agrin" 4 : 295-308, 2003
• 44 Lin, S, "Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice" 105 : 11406-11411, 2008
• 45 Suzuki, O.T, "Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome" 71 : 1320-1329, 2002
• 46 Bix, G, "Matrix revolutions: “tails” of basement-membrane components with angiostatic functions" 15 : 52-60, 2005
• 47 Iozzo,R.V, "Matrix proteoglycans: from molecular design to cellular function" 67 : 609-652, 1998
• 48 Gianazza, E, "Mapping the 5-50-kDa fraction of human amniotic fluid proteins by 2-DE and ESI-MS" 1 : 167-175, 2007
• 49 Burgess, R.W, "Mapping sites responsible for interactions of agrin with neurons" 83 : 271-284, 2002
• 50 Kim, N, "Lrp4 is a receptor for agrin and forms a complex with MuSK" 135 : 334-342, 2008
• 51 Moulton, K.S, "Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis" 110 : 1330-1336, 2004
• 52 Ylikärppä, R, "Lack of type XVIII collagen results in anterior ocular defects" 17 : 2257-2259, 2003
• 53 Fukai, N, "Lack of collagen XVIII/endostatin results in eye abnormalities" 21 : 1535-1544, 2002
• 54 Seppinen, L, "Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing" 27 : 535-546, 2008
• 55 Menzel, O, "Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired po-lymorphism in endostatin" 23 : 77-84, 2004
• 56 Oh, S.P, "Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins" 91 : 4229-4233, 1994
• 57 Rehn, M, "Interaction of endostatin with integrins implicated in angiogenesis" 98 : 1024-1029, 2001
• 58 Woodall, B.P, "Integrin 21 is the required receptor for endorepellin angiostatic activity" 283 : 2335-2343, 2008
• 59 Zweers, M.C, "Integrin 21 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization" 127 : 467-478, 2007
• 60 Tran, P.-K, "Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan" 94 : 550-558, 2004
• 61 Li, Q, "Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice" 165 : 415-424, 2004
• 62 Zhou, Z, "Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice" 64 : 4699-4702, 2004
• 63 Chang, J.W, "Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer" 2 : 23-32, 2008
• 64 Vuadens, F, "Identification of biologic markers of the premature rupture of fetal membranes:proteomic approach" 3 : 1521-1525, 2003
• 65 Nitkin, R.M, "Identification of agrin, a synaptic organizing protein from Torpedo electric organ" 105 : 2471-2478, 1987
• 66 Costell, M, "Hyperplastic conotruncal endo-cardial cushions and transposition of great arteries in perlecan-null mice" 91 : 158-164, 2002
• 67 Sudhakar, A, "Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by v3 and 51 integrins" 100 : 4766-4771, 2003
• 68 Whitelock, J.M, "Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells" 18 : 163-178, 1999
• 69 Zorick, T.S, "High serum endostatin levels in Down syndrome: Implications for improved treatment and prevention of solid tumors" 9 : 811-814, 2001
• 70 Reiland, J, "Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion" 279 : 8047-8055, 2004
• 71 Whitelock, J.M, "Heparan sulfate: a complex polymer charged with biological activity" 105 : 2745-2764, 2005
• 72 Iozzo, R.V, "Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena" 108 : 349-355, 2001
• 73 Rossi, M, "Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney" 22 : 236-245, 2003
• 74 Baerwald-De La Torre, K, "Glycosaminoglycan-dependent and -independent inhibition of neurite outgrowth by agrin" 90 : 50-61, 2004
• 75 Ferreras, M, "Generation and degradation of human endostatin proteins by various proteinases" 486 : 247-251, 2000
• 76 Mongiat, M, "Fibroblast growth factor-binding protein is a novel partner for perlecan protein core" 276 : 10263-10271, 2001
• 77 Nugent, M.A, "Fibroblast growth factor-2" 32 : 115-120, 2000
• 78 Dong, S, "Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites" 278 : 1700-1707, 2003
• 79 Abdollahi, A, "Endostatin’s antioangiogenic signaling network" 13 : 649-663, 2004
• 80 O’Reilly, M.S, "Endostatin:an endogenous inhibitor of angiogenesis and tumor growth" 88 : 277-285, 1997
• 81 Wickström, S.A, "Endostatin signaling and regulation of endothelial cell-matrix interactions" 94 : 197-229, 2005
• 82 Dhanabal, M, "Endostatin induces endothelial cell apoptosis" 274 : 11721-11726, 1999
• 83 Kim, Y.-M, "Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1" 277 : 27872-27879, 2002
• 84 Bix, G, "Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the 21 integrin receptor" 109 : 3745-3748, 2007
• 85 Mongiat, M, "Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan" 278 : 4238-4249, 2003
• 86 Bix, G, "Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism" 98 : 1634-1646, 2006
• 87 Bix, G, "Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through the 21 integrin" 166 : 97-109, 2004
• 88 Sund, M, "Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers:basic science to clinical application" 129 : 2076-2091, 2005
• 89 Nyberg, P, "Endogenous inhibitors of angiogenesis" 65 : 3967-3979, 2005
• 90 Marneros, A.G, "Endogenous endostatin inhibits choroidal neovascularization" 21 : 3809-3818, 2007
• 91 Denzer, A.J, "Electron microscopic structure of agrin and mapping of its binding site in laminin-1" 17 : 335-343, 1998
• 92 Whitelock, J.M, "Diverse cell signaling events modulated by perlecan" 47 : 11174-11183, 2008
• 93 Lin, W, "Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse" 410 : 1057-1064, 2001
• 94 Handler, M, "Developmental expression of perlecan during murine embryogenesis" 210 : 130-145, 1997
• 95 González-Iriarte, M, "Development of the coronary arteries in a murine model of transposition of great arteries" 35 : 795-802, 2003
• 96 Gautam, M, "Defective neuromuscular synaptogenesis in agrin-deficient mice" 85 : 525-535, 1996
• 97 Saarela, J, "Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts" 16 : 319-328, 1998
• 98 Batmunkh, E, "Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepa-tocellular carcinoma" 38 : 1508-1515, 2007
• 99 Zatterstrom, U.K, "Collagen XVIII/endostatin structure and functional role in angiogenesis" 25 : 97-101, 2000
• 100 Marneros, A.G, "Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function" 23 : 89-99, 2004
• 101 Halfter, W, "Collagen XVIII is a basement membrane heparan sulfate proteoglycan" 273 : 25404-25412, 1998
• 102 Matsumoto-Miyai, K, "Coincident pre-and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage" 136 : 1161-1171, 2009
• 103 Oh, S.P, "Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the 1(XVIII)collagen gene to mouse chromosome 10 and human chromosome 21" 19 : 494-499, 1994
• 104 Elamaa, H, "Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif" 22 : 427-442, 2003
• 105 West, L, "Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate" 24 : 1317-1326, 2006
• 106 Karumanchi, S.A, "Cell surface glypicans are low-affinity endostatin receptors" 7 : 811-822, 2001
• 107 Cailhier, J.-F, "Caspase-3 activation triggers extracellular release of cathepsin L and endorepellin proteolysis" 283 : 27220-27229, 2008
• 108 Grønborg, M, "Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach" 5 : 157-171, 2006
• 109 Iozzo,R.V, "Basement membrane proteoglycans: from cellar to ceiling" 6 : 646-656, 2005
• 110 Yurchenco, P.D, "Basement membrane assembly, stability and activities observed through a developmental lens" 22 : 521-538, 2004
• 111 Gonzalez, E.M, "BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan" 280 : 7080-7087, 2005
• 112 Raymond, M.-A, "Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on vascular smooth muscle cells" 18 : 705-707, 2004
• 113 Sharma, B, "Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo" 102 : 1599-1608, 1998
• 114 Shichiri, M, "Antiangiogenesis signals by endostatin" 15 : 1044-1053, 2001
• 115 Sweeney, S.M, "Angiogenesis in collagen I requires 21 ligation of a GFP*GER sequence and possible p38 MAPK activation and focal adhesion disassembly" 278 : 30516-30524, 2003
• 116 Tátrai, P, "Agrin, a novel basement membrane component in human rat and liver, accumulates in cirrhosis and hepatocellular carcinoma" 86 : 1149-1160, 2006
• 117 Zhang, J, "Agrin is involved in lymphocytes activation that is mediated by -dystroglycan" 20 : 50-58, 2006
• 118 Verbeek, M.M, "Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer’s disease brain" 155 : 2115-2125, 1999
• 119 Gesemann, M, "Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue" 273 : 600-605, 1998
• 120 Winzen, U, "Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters" 278 : 30106-30114, 2003
• 121 Donahue, J.E, "Agrin in Alzheimer’s disease: Altered solubility and abnormal distribution within microvasculature and brain parenchyma" 96 : 6468-6472, 1999
• 122 Sauter, B.V, "Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastasis" 97 : 4802-4807, 2001
• 123 Scotton, P, "Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin" 281 : 36835-36845, 2006
• 124 Hurskainen, M, "Abnormal maturation of the retinal vasculature in type XVIII collagen/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII" 19 : 1564-1666, 2005
• 125 Cohen, I.R, "Abnormal expression of perlecan proteoglycan in metastatic melanomas" 54 : 5771-5774, 1994
• 126 Ghiselli, G, "A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor" 359 : 153-163, 2001
• 127 Mathiak, M, "A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells" 57 : 2130-2136, 1997
• 128 Zoeller, J.J, "A central function for perlecan in skeletal muscle and cardiovascular development" 181 : 381-394, 2008
• 129 Hilgenberg, L.G.W, "3Na+/K+-ATPase is a neuronal receptor for agrin" 125 : 359-369, 2006